MedTrace Logo

Risk Reduction in Coronary Heart Disease

NCT00679237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1600

Last updated 2021-03-17

No results posted yet for this study

Summary

Study hypothesis: Multifactorial risk reduction in coronary heart disease can reduce the risk of new coronary heart disease and death

Conditions

Interventions

BEHAVIORAL

smoking cessation

NRT and varenicline

DRUG

betablocker, diuretics, ACEI, ARB,

blood pressure control according to ESC guidelines

DRUG

statins, ezetimibe

Cholesterol reduction according to ESC guidelines

BEHAVIORAL

training

daily walking

BIOLOGICAL

influenza vaccine

vaccine (FLuarix, Influvac etc)

DRUG

metformin, glimepiride, insulin

s.glucose control according to ESC guidelines

BEHAVIORAL

weight reduction

diet tips

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER

  • Sorlandet Hospital HF

    lead OTHER_GOV

Principal Investigators

  • Serena Tonstad, dr.med. · Ullevaal University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00679237 on ClinicalTrials.gov